# Robert B. Molpus, M.D. – FDA Inspection, Aug 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/robert-b-molpus-md/bf51b9bd-7f4c-4138-a96b-09d60a44c2c2
Source feed: FDA_Inspections

> FDA inspection 1333912 of Robert B. Molpus, M.D., August 28, 2026. 2 citations under 21 CFR part 312. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1333912
- Company Name: Robert B. Molpus, M.D.
- Inspection Date: 2026-08-28
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1266065 - 2025-04-03](https://www.keypedia.com/records/fda_inspections/robert-b-molpus-md/a3a7a1cc-83dc-432d-807c-b450bc9d442a)
- FDA Inspection 1127812 - 2020-08-10
- FDA Inspection 1039869 - 2018-01-26

## Related Officers

- [Company Rep](https://www.keypedia.com/people/chinyere-a-asanya/5d417b03-0ebb-4903-9626-3528d9d95536)
- [Issuing Officer](https://www.keypedia.com/people/nicol-vargas/e3d5cbee-35bf-4079-b6fc-5e9c3101ebf2)

Company: https://www.keypedia.com/companies/robert-b-molpus-md/85c57cdc-e62c-46e2-83e4-a4c22ae846ad

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9